NCT01123278View on ClinicalTrials.gov

Testosterone Replacement in Metabolic Syndrome and Inflammation

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
HypogonadismMetabolic SyndromeObesityErectile Dysfunction
Interventions
DRUG

Testosterone

Testosterone transdermal gel 50 mg/day (5 gr)

DRUG

Placebo

Placebo transdermal gel (5 gr)

Trial Locations (2)

00161

Policlinico Umberto I Hospital - Sapienza University, Rome

Dipartimento di Fisiopatologia Medica - Policlinico Umberto I, Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT01123278 - Testosterone Replacement in Metabolic Syndrome and Inflammation | Biotech Hunter | Biotech Hunter